Pentadecapeptide Arginate (PDA)
Pentadecapeptide Arginate, or PDA, is a synthetic peptide related to BPC-157. The pharmacy dispenses it as a compounded 10mg/mL injectable in two vial sizes. Compounded medications are not FDA-approved, and it is prescribed only after a licensed provider reviews your history.
Your path to Pentadecapeptide Arginate (PDA)
Complete the assessment
Share your health, training, and wellness goals in the patient portal.
Provider review
A licensed provider decides whether PDA fits your situation and what to prescribe.
Care coordination
Your care team coordinates the prescription and dosing supplies after provider approval.
About this treatment
What it is
PDA is a 15-amino-acid peptide, an arginate salt form related to BPC-157. IAM dispenses it as a compounded injectable. Research on it is early, and your provider will go over what is and is not known before prescribing.
Who it's for
Adults whose provider decides it fits after reviewing their history and current medications. Ask your provider whether it belongs in your plan.
Forms we dispense
Injectable 10mg/mL
A licensed provider reviews your history and requests labs when clinically appropriate before prescribing.
Prescriptions are coordinated with our licensed US pharmacy partner, with dosing supplies included when needed.
We do not sell pharmaceuticals online. Every prescription comes after a full provider review.
